Genocea Biosciences
Immunotherapy company that developed personalized cancer vaccines targeting neoantigens using its proprietary ATLAS platform. Ceased operations in 2022 after clinical and financial challenges.
Location
Cambridge, Massachusetts, USA
Founded
2006
Investors
1
Categories
biotech, immunotherapy, cancer-vaccines, neoantigens, defunct
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Polaris Partners | US | biotech-focused | - | 33 |